Expected Impact
Contribute to Building the Foundation for Developing Immune Cell Gene Therapies by Focusing on CAR-T, TCR-T, and TIL Technologies for Solid Tumors
- Building an Integrated R&D Ecosystem
- Establishing a collaborative research network across industry, academia, research institutes, and hospitals, encompassing clinical research, clinical-grade viral vector production, and cell manufacturing for CAR-T, TCR-T, and TIL therapies.
- Establishing a National Cancer Database
- Building a centralized repository integrating neoantigen immunogenicity, infused cell characterization, and clinical therapeutic response data for the National Cancer Data Center
Reducing the Economic Burden of Cancer Care through Advanced Regenerative Cancer Therapeutucs
- Strengthening National Competitiveness through Advanced Clinical Research Infrastructure
- Building a clinical research foundation for CAR-T, TCR-T, and TIL therapies to accelerate commercialization in Korea
- Reducing the Economic Burden of Cancer Treatment
- Advancing innovative, locally developed cancer therapies will enhance patient access to care